Diminished muscle growth in the obese Zucker rat following overload is associated with hyperphosphorylation of AMPK and dsRNA-dependent protein kinase

Journal of Applied Physiology

Volumn 113, Issue 3, 2012, Pages 377-384

  Katta, Anjaiah ^a,b   Kakarla, Sunil K ^a,b   Manne, Nandini D P K ^a,b   Wu, Miaozong ^a   Kundla, Sudarsanam ^a   Kolli, Madhukar B ^a,b   Nalabotu, Siva K ^a,b   Blough, Eric R ^a,b  

^a MARSHALL UNIVERSITY   (United States)

^b MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hypertrophy; Obese Zucker rat; Skeletal muscle

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE R; SERINE; THREONINE; TYROSINE;

ANIMAL; ARTICLE; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; INSULIN RESISTANCE; MALE; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; UBIQUITINATION; ZUCKER RAT;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; EIF-2 KINASE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INSULIN RESISTANCE; MALE; MUSCLE, SKELETAL; OBESITY; PHOSPHORYLATION; RATS; RATS, ZUCKER; SERINE; SIGNAL TRANSDUCTION; THREONINE; TYROSINE; UBIQUITINATION;

EID: 84864585946     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00397.2011     Document Type: Article

References (40)

1. Blough ER, Linderman JK. Lack of skeletal muscle hypertrophy in very aged male Fischer 344 × Brown Norway rats. J Appl Physiol 88:1265-1270, 2000. (Pubitemid 30217424)
2. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3:1014-1019, 2001. (Pubitemid 34428747)
3. Bolster DR, Crozier SJ, Kimball SR, Jefferson LS. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem 277:23977-23980, 2002. (Pubitemid 34951907)
4. Bolster DR, Kubica N, Crozier SJ, Williamson DL, Farrell PA, Kimball SR, Jefferson LS. Immediate response of mammalian target of rapamycin (mTOR)-mediated signalling following acute resistance exercise in rat skeletal muscle. J Physiol 553:213-220, 2003. (Pubitemid 37483929)
5. Carling D, Aguan K, Woods A, Verhoeven AJ, Beri RK, Brennan CH, Sidebottom C, Davison MD, Scott J. Mammalian AMP-activated protein kinase is homologous to yeast and plant protein kinases involved in the regulation of carbon metabolism. J Biol Chem 269:11442-11448, 1994. (Pubitemid 24200360)
6. Eley HL, Russell ST, Tisdale MJ. Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor, and angiotensin II by beta-hydroxy-beta-methylbutyrate. Am J Physiol Endocrinol Metab 295:E1409-E1416, 2008.
7. Eley HL, Russell ST, Tisdale MJ. Mechanism of activation of dsRNAdependent protein kinase (PKR) in muscle atrophy. Cell Signal 22:783-790.
8. Eley HL, Russell ST, Tisdale MJ. Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-alpha and angiotensin II by beta-hydroxy-beta-methylbutyrate. Am J Physiol Endocrinol Metab 295:E1417-E1426, 2008.
9. Eley HL, Skipworth RJ, Deans DA, Fearon KC, Tisdale MJ. Increased expression of phosphorylated forms of RNA-dependent protein kinase and eukaryotic initiation factor 2alpha may signal skeletal muscle atrophy in weight-losing cancer patients. Br J Cancer 98:443-449, 2008. (Pubitemid 351161247)
10. Eley HL, Tisdale MJ. Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation. J Biol Chem 282:7087-7097, 2007. (Pubitemid 47093637)
11. Gil J, Esteban M. Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis 5:107-114, 2000. (Pubitemid 30399384)
12. Haq S, Choukroun G, Kang ZB, Ranu H, Matsui T, Rosenzweig A, Molkentin JD, Alessandrini A, Woodgett J, Hajjar R, Michael A, Force T. Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy. J Cell Biol 151:117-130, 2000.
13. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR, Hardie DG. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2:28, 2003.
14. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG, Hardie DG. Calmodulin-dependent protein kinase kinasebeta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2:9-19, 2005. (Pubitemid 43239821)
15. Holcik M, Sonenberg N. Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 6:318-327, 2005. (Pubitemid 40516898)
16. Jefferson LS, Fabian JR, Kimball SR. Glycogen synthase kinase-3 is the predominant insulin-regulated eukaryotic initiation factor 2B kinase in skeletal muscle. Int J Biochem Cell Biol 31:191-200, 1999. (Pubitemid 29094799)
17. Katta A, Kakarla S, Wu M, Paturi S, Gadde MK, Arvapalli R, Kolli M, Rice KM, Blough ER. Altered regulation of contraction-induced Akt/mTOR/p70S6k pathway signaling in skeletal muscle of the obese Zucker rat. Exp Diabetes Res 2009:384683, 2009.
18. Katta A, Karkala SK, Wu M, Meduru S, Desai DH, Rice KM, Blough ER. Lean and obese Zucker rats exhibit different patterns of p70s6 kinase regulation in the tibialis anterior muscle in response to high-force muscle contraction. Muscle Nerve 39:503-511, 2009.
19. Katta A, Kundla S, Kakarla SK, Wu M, Fannin J, Paturi S, Liu H, Addagarla HS, Blough ER. Impaired overload-induced hypertrophy is associated with diminished mTOR signaling in insulin-resistant skeletal muscle of the obese Zucker rat. Am J Physiol Regul Integr Comp Physiol 299:R1666-R1675, 2010.
20. Marette A. The AMPK signaling cascade in metabolic regulation: view from the chair. Int J Obes (Lond) 32, Suppl 4:S3-S6, 2008.
21. Momcilovic M, Hong SP, Carlson M. Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J Biol Chem 281:25336-25343, 2006. (Pubitemid 44401921)
22. Nader GA, Hornberger TA, Esser KA. Translational control: implications for skeletal muscle hypertrophy. Clin Orthop Relat Res S178-S187, 2002. (Pubitemid 35346004)
23. Paturi S, Gutta AK, Kakarla SK, Katta A, Arnold EC, Wu M, Rice KM, Blough ER. Impaired overload-induced hypertrophy in Obese Zucker rat slow-twitch skeletal muscle. J Appl Physiol 108:7-13, 2010.
24. Reynolds THt Bodine SC, Lawrence JC Jr. Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load. J Biol Chem 277:17657-17662, 2002. (Pubitemid 34967569)
25. Russell ST, Rajani S, Dhadda RS, Tisdale MJ. Mechanism of induction of muscle protein loss by hyperglycaemia. Exp Cell Res 315:16-25, 2009.
26. Russell ST, Siren PM, Siren MJ, Tisdale MJ. Mechanism of attenuation of protein loss in murine C2C12 myotubes by D-myo-inositol 1, 2, 6-triphosphate. Exp Cell Res 316:286-295.
27. Russell ST, Tisdale MJ. Mechanism of attenuation by beta-hydroxy- betamethylbutyrate of muscle protein degradation induced by lipopolysaccharide. Mol Cell Biochem 330:171-179, 2009.
28. Sakamoto K, McCarthy A, Smith D, Green KA, Grahame Hardie D, Ashworth A, Alessi DR. Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J 24:1810-1820, 2005. (Pubitemid 40769500)
29. Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, DePinho RA, Cantley LC. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci USA 101:3329-3335, 2004. (Pubitemid 38338195)
30. 2+/calmodulin- dependent protein kinase kinase is involved in AMP-activated protein kinase activation by alpha-lipoic acid in C2C12 myotubes. Am J Physiol Cell Physiol 293:C1395-C1403, 2007. (Pubitemid 47556748)
31. Song P, Xie Z, Wu Y, Xu J, Dong Y, Zou MH. Protein kinase Czeta-dependent LKB1 serine 428 phosphorylation increases LKB1 nucleus export and apoptosis in endothelial cells. J Biol Chem 283:12446-12455, 2008.
32. Su V, Lau AF. Ubiquitin-like and ubiquitin-associated domain proteins: significance in proteasomal degradation. Cell Mol Life Sci 66:2819-2833, 2009.
33. Thomson DM, Gordon SE. Diminished overload-induced hypertrophy in aged fast-twitch skeletal muscle is associated with AMPK hyperphosphorylation. J Appl Physiol 98:557-564, 2005. (Pubitemid 40129965)
34. Witczak CA, Sharoff CG, Goodyear LJ. AMP-activated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism. Cell Mol Life Sci 65:3737-3755, 2008.
35. 2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2:21-33, 2005. (Pubitemid 43239822)
36. Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, Schlattner U, Wallimann T, Carlson M, Carling D. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13:2004-2008, 2003. (Pubitemid 37425212)
37. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 124:471-484, 2006. (Pubitemid 43199434)
38. Xie M, Zhang D, Dyck JR, Li Y, Zhang H, Morishima M, Mann DL, Taffet GE, Baldini A, Khoury DS, Schneider MD. A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc Natl Acad Sci USA 103:17378-17383, 2006. (Pubitemid 44788977)
39. Yamauchi M, Kambe F, Cao X, Lu X, Kozaki Y, Oiso Y, Seo H. Thyroid hormone activates adenosine 5′-monophosphate-activated protein kinase via intracellular calcium mobilization and activation of calcium/calmodulin- dependent protein kinase kinase-beta. Mol Endocrinol 22:893-903, 2008. (Pubitemid 351482825)
40. Zucker LM. Fat mobilization in vitro and in vivo in the genetically obese Zucker rat "fatty". J Lipid Res 13:234-243, 1972.